Broader Implications of Defining Standards for the Pluripotency of iPSCs
Broader Implications of Defining Standards for the Pluripotency of iPSCs_1.pdf (63.87Kb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
MetadataShow full item record
CitationDaley, George Q., M. William Lensch, Rudolf Jaenisch, Alex Meissner, Kathrin Plath, and Shinya Yamanaka. 2009. “Broader Implications of Defining Standards for the Pluripotency of iPSCs.” Cell Stem Cell 4 (3) (March): 200–201. doi:10.1016/j.stem.2009.02.009.
AbstractWe read with great interest the excellent review by Maherali and Hochedlinger (2008) that recommends standards for characterization of pluripotent stem cell lines, especially the many new lines being generated using factor-based reprogramming techniques (induced pluripotent stem cells, or iPSCs). Of note was the suggestion that iPSCs should be assessed for “functional differentiation through the highest-stringency test acceptable.” For murine iPSCs, this means germline transmission following blastocyst chimerism, and for human iPSCs this means assessment of teratoma pathology.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33471099
- HMS Scholarly Articles